| AChE | Acetylcholinesterase |
| AD | Alzheimer’s disease |
| AMPA | α-amino-3-hydroxy-5-methyl-D-aspartate |
| Aβ | Amyloid-β |
| APP | Amyloid precursor protein |
| BACE1 | β-secretase |
| BBB | Blood–brain barrier |
| BCCAO | Bilateral common carotid artery occlusion |
| BDNF | Brain-derived neurotrophic factor |
| CaMKII | Calcium/calmodulin-dependent protein kinase II |
| CREB | cAMP response element-binding protein |
| DARPP-32 | Dopamine- and cAMP-regulated phosphoprotein-32 |
| ER | Endoplasmic reticulum |
| ERK | Extracellular signal-regulated kinase |
| GSH | Glutathione |
| GSSG | Glutathione disulfide |
| HO | Hemeoxygenase |
| IL | Interleukin |
| iPS | Induced pluripotent stem |
| I/R | Ischemia-reperfusion |
| JNK | c-Jun N-terminal kinase |
| LPS | Lipopolysaccharide |
| LTP | Long-term potentiation |
| MAP2 | Microtubule-associated protein 2 |
| MDA | Malondialdehyde |
| MMP | Matrix metalloproteinase |
| MPP+ | Matrix metalloproteinase |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| NMDA | N-methyl-D-aspartate |
| OBX | Olfactory-bulbectomized |
| PDE | Phosphodiesterase |
| PKA | Protein kinase A |
| p-MCAO | Permanent middle cerebral artery occlusion |
| PD | Parkinson’s disease |
| SAMP8 | Senescence-accelerated-prone mouse 8 |
| SNpc | Substantia nigra pars compacta |
| SOD | Superoxide dismutase |
| TH | Tyrosine hydroxylase |
| t-MCAO | Transient middle cerebral artery occlusion |
| TNF | Tumor necrosis factor |
| VTA | Ventral tegmental area |